Injunction Stops Sales Of Qiagen GeneReader

12 Sep 2016
News

Elizabeth Orr @elizabethjorr elizabeth.orr@informa.com

Executive Summary

The system was launched late last year, but a preliminary injunction issued by a federal court in California will now block Qiagen from marketing its GeneReader sequencing system in the US. Illumina had filed a patent claim against the system, and the court found that the claim is likely to succeed.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Medical Device In Vitro Diagnostics Commercial

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT103819

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT103819

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Injunction Stops Sales Of Qiagen GeneReader

News

Executive Summary

Related Content

Qiagen Moves Into Next-Gen Sequencing

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert